Company: HURA
Filing Date: 2025-03-12
Form Type: 8-K
Source: 0000950170-25-037600
Chunk: 0

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-12
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure.

On March 10, 2025, the Company issued a press release announcing the appointment of Dr. Tendler to the Board, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information set forth in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), nor shall it be deemed incorporated by reference in any of the Company’s filings under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.